

Novo Nordisk Foundation is a philanthropic institution that deploys capital across health, research, and social impact domains, with a particular focus on addressing global health inequities and supporting innovation in life sciences and social entrepreneurship. The foundation operates through grants, program-related investments, and strategic partnerships, directing resources toward initiatives that advance diabetes care, obesity prevention, and broader determinants of health in lower and middle-income countries and vulnerable populations. Its investment strategy emphasizes catalytic capital that bridges gaps between early-stage innovation and scalable impact, including support for social e...
Asset class
Impact theme
Investment geographies
